Gene · 6510
Papers3,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,624
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neddylation steers the fate of cellular receptors. | Exp Mol Med | 2024 | 39623094 | PubTator, text mining | PubMed |
| Approaches to investigate tissue-resident innate lymphocytes metabolism at the single-cell level. | Nat Commun | 2024 | 39613733 | PubTator, text mining | PubMed |
| Identification and characterization of novel ferroptosis-related genes in acute myocardial infarction. | Hum Genomics | 2024 | 39538299 | PubTator, text mining | PubMed |
| Hydroxyacid Oxidase 1, a Glutamine Metabolism-Associated Protein, Predicts Poor Patient Outcome in Luminal Breast Cancer. | Int J Mol Sci | 2024 | 39519124 | PubTator, text mining | PubMed |
| DON encapsulated carbon dot-vesicle conjugate in therapeutic intervention of lung adenocarcinoma by dual targeting of CD44 and SLC1A5. | Nanoscale | 2024 | 39513401 | PubTator, text mining | PubMed |
| Nutritional Glutamine-Modified Iron-Delivery System with Enhanced Endocytosis for Ferroptosis Therapy of Pancreatic Tumors. | ACS Nano | 2024 | 39512234 | PubTator, text mining | PubMed |
| Integrated stress response-upregulated mitochondrial SLC1A5var enhances glucose dependency in human breast cancer cells in vitro. | Int J Biochem Cell Biol | 2024 | 39505107 | PubTator, text mining | PubMed |
| Immunometabolism: signaling pathways, homeostasis, and therapeutic targets. | MedComm (2020) | 2024 | 39492834 | PubTator, text mining | PubMed |
| LINC01134 Directly Binds and Regulates SLC1A5 Stability to Promotes Colorectal Cancer Progression. | J Cancer | 2024 | 39440055 | PubTator, text mining | PubMed |
| Receptor usage of Syncytin-1: ASCT2, but not ASCT1, is a functional receptor and effector of cell fusion in the human placenta. | Proc Natl Acad Sci U S A | 2024 | 39432789 | PubTator, text mining | PubMed |
| Tumor-derived extracellular vesicles convey solute transporters to induce bioenergetic dependence shift contributing to treatment resistance. | Theranostics | 2024 | 39431017 | PubTator, text mining | PubMed |
| Macropinocytosis mediates resistance to loss of glutamine transport in triple-negative breast cancer. | EMBO J | 2024 | 39420093 | PubTator, text mining | PubMed |
| Identification of a novel prognostic model for gastric cancer utilizing glutamine-related genes. | Heliyon | 2024 | 39386842 | PubTator, text mining | PubMed |
| Benzo(a)anthracene Targeting SLC1A5 to Synergistically Enhance PAH Mixture Toxicity. | Environ Sci Technol | 2024 | 39373333 | PubTator, text mining | PubMed |
| Asparagine as a signal for glutamine sufficiency via asparagine synthetase: a fresh evidence-based framework in physiology and oncology. | Am J Physiol Cell Physiol | 2024 | 39344414 | PubTator, text mining | PubMed |
| Identification of ENO-1 positive extracellular vesicles as a circulating biomarker for monitoring of Ewing sarcoma. | Cancer Sci | 2024 | 39307979 | PubTator, text mining | PubMed |
| Prognostic significance of LAT1 expression in pleural mesothelioma. | Heliyon | 2024 | 39290273 | PubTator, text mining | PubMed |
| ASCT2 Regulates Fatty Acid Metabolism to Trigger Glutamine Addiction in Basal-like Breast Cancer. | Cancers (Basel) | 2024 | 39272886 | PubTator, text mining | PubMed |
| Abnormal Cellular Populations Shape Thymic Epithelial Tumor Heterogeneity and Anti-Tumor by Blocking Metabolic Interactions in Organoids. | Adv Sci (Weinh) | 2024 | 39258580 | PubTator, text mining | PubMed |
| Combinatorial targeting of glutamine metabolism and lysosomal-based lipid metabolism effectively suppresses glioblastoma. | Cell Rep Med | 2024 | 39236712 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6510/papers?page=12